ConductScience.org, home

Paper30002297

Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.

Zayed MF and 4 others. Molecules, 2018. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization. Papers, record 30002297. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30002297

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.
PubMed
Journal
Molecules
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2018-12-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zayed MFMohamed F
2Rateb HSHeba S
3Ahmed SSahar
4Khaled OAOsama A
5Ibrahim SRMSabrin R M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErbB ReceptorsMajor topic
Molecular Docking SimulationMajor topic
Protein Kinase InhibitorsMajor topic
QuinazolinesMajor topic
TubulinMajor topic
Tubulin ModulatorsMajor topic
Humans
MCF-7 Cells

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125174978Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives.Cent Nerv Syst Agents Med Chem2014https://conductscience.org/library/papers/25174978PubMed
210592235The Protein Data Bank.Nucleic Acids Res2000https://conductscience.org/library/papers/10592235PubMed
318950904Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.Eur J Med Chem2009https://conductscience.org/library/papers/18950904PubMed
419664865
Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I.
Eur J Med Chem2009https://conductscience.org/library/papers/19664865PubMed
516971132Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.Bioorg Med Chem2006https://conductscience.org/library/papers/16971132PubMed
624801610Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.J Med Chem2014https://conductscience.org/library/papers/24801610PubMed
724648828Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents.Saudi Pharm J2014https://conductscience.org/library/papers/24648828PubMed
81731931Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes.Biochemistry1992https://conductscience.org/library/papers/1731931PubMed
923487401Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents.Drug Res (Stuttg)2013https://conductscience.org/library/papers/23487401PubMed
1015072839Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones.Eur J Med Chem2004https://conductscience.org/library/papers/15072839PubMed
1128215601Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.Bioorg Chem2017https://conductscience.org/library/papers/28215601PubMed
1227589739The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach.Int J Mol Sci2016https://conductscience.org/library/papers/27589739PubMed
1329891789Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.Int J Mol Sci2018https://conductscience.org/library/papers/29891789PubMed
1429385728The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization.Int J Mol Sci2018https://conductscience.org/library/papers/29385728PubMed
1512735990Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones.Bioorg Med Chem2003https://conductscience.org/library/papers/12735990PubMed
1622551678New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies.Eur J Med Chem2012https://conductscience.org/library/papers/22551678PubMed
1728838691Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase.Bioorg Med Chem Lett2017https://conductscience.org/library/papers/28838691PubMed
1820724039Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.Eur J Med Chem2010https://conductscience.org/library/papers/20724039PubMed
1912384534ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.Cancer Res2002https://conductscience.org/library/papers/12384534PubMed
2020510483Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1.Eur J Med Chem2010https://conductscience.org/library/papers/20510483PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42196461Synthesis and Biological Evaluation of New Quinazolin-4(3H)-One-Coumarin Hybrids Designed as Anticancer and Antibacterial Agents.Int J Mol Sci2026https://conductscience.org/library/papers/42196461PubMed
41599658Design, Synthesis, and Biological Evaluation of N-Acyl-Hydrazone-Linked Quinazolinone Derivatives with Antioxidant, Antimicrobial, and Anticancer Potential.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599658PubMed
41379296Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.Mol Divers2026https://conductscience.org/library/papers/41379296PubMed
41053651Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases.BMC Cancer2025https://conductscience.org/library/papers/41053651PubMed
40106127Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy.Mol Divers2025https://conductscience.org/library/papers/40106127PubMed
40001513Quinazolinones as Potential Anticancer Agents: Synthesis and Action Mechanisms.Biomolecules2025https://conductscience.org/library/papers/40001513PubMed
39390838Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway.Curr Med Chem2025https://conductscience.org/library/papers/39390838PubMed
38899242Quinazoline Derivatives as Targeted Chemotherapeutic Agents.Cureus2024https://conductscience.org/library/papers/38899242PubMed
37259442Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37259442PubMed
36790582New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization.Mol Divers2024https://conductscience.org/library/papers/36790582PubMed
35516563Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.RSC Adv2020https://conductscience.org/library/papers/35516563PubMed
35409361A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.Int J Mol Sci2022https://conductscience.org/library/papers/35409361PubMed
35269887MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents-A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives.Int J Mol Sci2022https://conductscience.org/library/papers/35269887PubMed
34074193Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells.J Enzyme Inhib Med Chem2021https://conductscience.org/library/papers/34074193PubMed
31967481Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment.J Enzyme Inhib Med Chem2020https://conductscience.org/library/papers/31967481PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
NR4A38013PubTator's text mininghttps://conductscience.org/library/genes/8013NCBI Gene
TYMS7298PubTator's text mininghttps://conductscience.org/library/genes/7298NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30002297

GET https://conductscience.org/api/papers/v1/30002297/authors